Related Experiment Video
Updated: Dec 4, 2025

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Leprosy in Nepal: a re-emerging threat
Frank Houghton1, Michael Winterburn2
1HEALR Research Group, Limerick Institute of Technology, Limerick, Ireland. Frank.Houghton@LIT.ie.
Leprosy, once thought eliminated in Nepal in 2010, is now increasing. A national active case-finding program is urgently needed to address this resurgence of the disease.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Nepal has historically been recognized as a country with endemic leprosy.
- The World Health Organization's (WHO) guidelines were applied in Nepal in 2010.
- This application led to a declaration of leprosy 'elimination' in the country.
Purpose of the Study:
- To analyze the impact of the 2010 leprosy elimination declaration in Nepal.
- To highlight the current rise in leprosy cases.
- To advocate for the implementation of a national active case-finding program.
Main Methods:
- Review of historical leprosy data in Nepal.
- Analysis of the implications of the WHO's 2010 elimination criteria.
- Assessment of current leprosy trends and their contributing factors.
Main Results:
- The 2010 determination of leprosy elimination in Nepal was a misnomer.
- Leprosy prevalence has been increasing in Nepal.
- The 'elimination' status has masked the ongoing transmission and rise of the disease.
Conclusions:
- The declaration of leprosy elimination in Nepal was premature and inaccurate.
- There is an urgent need for a comprehensive national active case-finding program.
- Such a program is crucial to effectively control and reduce the increasing burden of leprosy in Nepal.
More Related Videos
09:39DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
Published on: July 15, 2011
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...